Lasers in Medical Science

, Volume 33, Issue 4, pp 891–897 | Cite as

Transurethral vaporesection of prostate: diode laser or thulium laser?

  • Xinji Tan
  • Xiaobo Zhang
  • Dongjie Li
  • Xiong Chen
  • Yuanqing Dai
  • Jie Gu
  • Mingquan Chen
  • Sheng Hu
  • Yao Bai
  • Yu Ning
Original Article


This study compared the safety and effectiveness of the diode laser and thulium laser during prostate transurethral vaporesection for treating benign prostate hyperplasia (BPH). We retrospectively analyzed 205 patients with BPH who underwent a diode laser or thulium laser technique for prostate transurethral vaporesection from June 2016 to June 2017 and who were followed up for 3 months. Baseline characteristics of the patients, perioperative data, postoperative outcomes, and complications were compared. We also assessed the International Prostate Symptom Score (IPSS), quality of life (QoL), maximum flow rate (Qmax), average flow rate (AFR), and postvoid residual volume (PVR) at 1 and 3 months postoperatively to evaluate the functional improvement of each group. There were no significant differences between the diode laser and thulium laser groups related to age, prostate volume, operative time, postoperative hospital stays, hospitalization costs, or perioperative data. The catheterization time was 3.5 ± 0.8 days for the diode laser group and 4.7 ± 1.8 days for the thulium laser group (p < 0.05). Each group had dramatic improvements in IPSS, QoL, Qmax, AFR, and PVR compared with the preoperative values (p < 0.05), although there were no significant differences between the two groups. Use of both diode laser and thulium laser contributes to safe, effective transurethral vaporesection in patients with symptomatic BPH. Diode laser, however, is better than thulium laser for prostate transurethral vaporesection because of its shorter catheterization time. The choice of surgical approach is more important than the choice of laser types during clinical decision making for transurethral laser prostatectomy.


Benign prostate hyperplasia Transurethral vaporesection of prostate Laser surgery Diode laser Thulium laser 


Funding information

This study was supported by the Natural Science Foundation of Hunan Province (Grant No. 14JJ7004) and Innovation Foundation For Postgraduate of Central South University (Grant No. 2017zzts887).

Compliance with ethical standards

Financial disclosure

The study was supported by the Natural Science Foundation of Hunan Province (Grant No. 14JJ7004) and Innovation Foundation For Postgraduate of Central South University (Grant No. 2017zzts887).

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this type of study, formal consent is not required.

Supplementary material

10103_2018_2499_MOESM1_ESM.docx (19 kb)
ESM 1 (DOCX 18 kb)


  1. 1.
    Zhang X, Zeng X, Liu Y, Dong L, Zhao X, Qu X (2014) Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men. Urol Int 93(2):214–219CrossRefPubMedGoogle Scholar
  2. 2.
    Yin Z, Yang JR, Rao JM, Song W, Zhou KQ (2015) Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men. ASIAN J ANDROL 17(5):826–830PubMedPubMedCentralGoogle Scholar
  3. 3.
    He LY, Zhang YC, He JL, Li LX, Wang Y, Tang J, Tan J, Zhong K, Tang YX, Long Z (2016) The effect of immediate surgical bipolar plasmakinetic transurethral resection of the prostate on prostatic hyperplasia with acute urinary retention. ASIAN J ANDROL 18(1):134–139CrossRefPubMedGoogle Scholar
  4. 4.
    Nair SM, Pimentel MA, Gilling PJ (2016) A review of laser treatment for symptomatic BPH (benign prostatic hyperplasia). CURR UROL REP 17(6)Google Scholar
  5. 5.
    Gravas S, Bach T, Bachmann A, Drake M, Gacci M, Gratzke C, Madersbacher S, Mamoulakis C, Tikkinen KAO Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). European Assoc Urology Guidelines 2016*ed 2016:32Google Scholar
  6. 6.
    Takada J, Honda N, Hazama H, Ioritani N, Awazu K (2016) Analysis of thermally denatured depth in laser vaporization for benign prostatic hyperplasia using a simulation of light propagation and heat transfer (secondary publication). LASER THERAPY 25(4):273–284CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Fu WJ, Hong BF, Yang Y, Zhang X, Gao JP, Zhang L, Wang XX (2009) Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow-up. BJU Int 103(3):352–356CrossRefPubMedGoogle Scholar
  8. 8.
    Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389CrossRefPubMedGoogle Scholar
  9. 9.
    Long Z, Zhang YC, He LY, Zhong KB, Tang YX, Huang K (2014) Comparison of transurethral plasmakinetic and transvesical prostatectomy in treatment of 100-149 mL benign prostatic hyperplasia. ASIAN J SURG 37(2):58–64CrossRefPubMedGoogle Scholar
  10. 10.
    Leonardi R (2009) Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis 12(3):277–280CrossRefPubMedGoogle Scholar
  11. 11.
    Zhao Y, Liu C, Zhou G, Yu C, Zhang Y, Ouyang Y (2013) A retrospective evaluation of benign prostatic hyperplasia treatment by transurethral vaporization using a 1470 nm laser. Photomed Laser Surg 31(12):626–629CrossRefPubMedGoogle Scholar
  12. 12.
    Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross AJ (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28(1):45–51CrossRefPubMedGoogle Scholar
  13. 13.
    Kim Y, Seong YK, Kim IG, Han BH (2013) Twelve-month follow-up results of photoselective vaporization of the prostate with a 980-nm diode laser for treatment of benign hyperplasia. Korean J Urology 54(10):677CrossRefGoogle Scholar
  14. 14.
    JIANG H, ZHOU Y (2016) Safety and efficacy of thulium laser prostatectomy versus transurethral resection of prostate for treatment of benign prostate hyperplasia: a meta-analysis. LUTS: Lower Urinary Tract Symptoms 8(3):165–170PubMedGoogle Scholar
  15. 15.
    Lee WC, Lin YH, Hou CP, Chang PL, Chen CL, Juang HH, Tsui KH (2013) Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males. Clin Interv Aging 8:1483–1488PubMedPubMedCentralGoogle Scholar
  16. 16.
    Erol A, Cam K, Tekin A, Memik O, Coban S, Ozer Y (2009) High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia. J Urol 182(3):1078–1082CrossRefPubMedGoogle Scholar
  17. 17.
    Barbalat Y, Velez MC, Sayegh CI, Chung DE (2016) Evidence of the efficacy and safety of the thulium laser in the treatment of men with benign prostatic obstruction. Ther Adv Urol 8(3):181–191CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Razzaghi MR, Mazloomfard MM, Mokhtarpour H, Moeini A (2014) Diode laser (980 nm) vaporization in comparison with transurethral resection of the prostate for benign prostatic hyperplasia: randomized clinical trial with 2-year follow-up. Urology 84(3):526–532CrossRefPubMedGoogle Scholar
  19. 19.
    Xu A, Zou Y, Li B, Liu C, Zheng S, Li H, Xu Y, Chen B, Xu K, Shen H (2013) A randomized trial comparing diode laser enucleation of the prostate with plasmakinetic enucleation and resection of the prostate for the treatment of benign prostatic hyperplasia. J Endourol 27(10):1254–1260CrossRefPubMedGoogle Scholar
  20. 20.
    Wang L, Yu QY, Liu Y, Zhu ZL, Huang YW, Li K (2016) Efficacy and safety of laser surgery and transurethral resection of the prostate for treating benign prostate hyperplasia: a network meta-analysis. Asian Pac J Cancer Prev 17(9):4281–4288PubMedGoogle Scholar
  21. 21.
    Seitz M, Ackermann A, Gratzke C, Schlenker B, Ruszat R, Bachmann A, Stief C, Reich O, Sroka R (2007) Diode laser. Ex vivo studies on vaporization and coagulation characteristics. Urologe A 46(9):1242–1247CrossRefPubMedGoogle Scholar
  22. 22.
    Nafie S, Dormer J, Khan MA (2017) The significance of histological analysis following laser transurethral resection of the prostate. Int Urol Nephrol 49(8):1343–1346CrossRefPubMedGoogle Scholar
  23. 23.
    Skinner T, Leslie RJ, Steele SS, Nickel JC (2017) Randomized, controlled trial of laser vs. bipolar plasma vaporization treatment of benign prostatic hyperplasia. Can Urol Assoc J 11(6):194–198CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Zhang X, Shen P, He Q, Yin X, Chen Z, Gui H, Shu K, Tang Q, Yang Y, Pan X, Wang J, Chen N, Zeng H (2016) Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis. SCI REP-UK 6(1):23503CrossRefGoogle Scholar
  25. 25.
    Peng M, Yi L, Wang Y (2016) Photoselective vaporization of the prostate vs plasmakinetic resection of the prostate: a randomized prospective trial with 12-month follow-up in mainland China. Urology 87:161–165CrossRefPubMedGoogle Scholar
  26. 26.
    Li D, Jiang X, Zhang X, Yi L, Zhu X, Zeng X, Guo X, Tang Y (2012) Multicenter pathophysiologic investigation of erectile dysfunction in clinic outpatients in China. Urology 79(3):601–606CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2018

Authors and Affiliations

  • Xinji Tan
    • 1
    • 2
  • Xiaobo Zhang
    • 1
    • 2
    • 3
    • 4
  • Dongjie Li
    • 1
  • Xiong Chen
    • 1
  • Yuanqing Dai
    • 2
  • Jie Gu
    • 1
    • 2
  • Mingquan Chen
    • 1
    • 2
  • Sheng Hu
    • 1
    • 2
  • Yao Bai
    • 1
    • 2
    • 4
  • Yu Ning
    • 5
  1. 1.Xiangya International Medical Center, Xiangya HospitalCentral South UniversityChangshaChina
  2. 2.The Department of Geriatric Urology, Xiangya HospitalCentral South UniversityChangshaChina
  3. 3.Urolithiasis Institute of Central South University, Xiangya HospitalCentral South UniversityChangshaChina
  4. 4.The Department of Urology, Xiangya HospitalCentral South UniversityChangshaChina
  5. 5.The Department of Anesthesiology, Xiangya HospitalCentral South UniversityChangshaChina

Personalised recommendations